Is KMB a good stock to buy? We came across a bullish thesis on Kimberly-Clark Corporation on MaxDividends’s Substack. In this article, we will summarize the bulls’ thesis on KMB. Kimberly-Clark Corporation’s share was trading at $108.10 as of June 25th. KMB’s trailing and forward P/E were 20.91 and 14.41 respectively according to Yahoo Finance.
Pixabay/Public Domain
Kimberly-Clark (KMB) is a global consumer staples company with leading positions in personal care, tissue, hygiene, and adult care products, and its investment case is increasingly centered on transforming the business into a more focused, higher-margin enterprise rather than simply driving higher sales volumes.
Read More: 15 AI Stocks That Are Quietly Making Investors Rich
Read More: Undervalued AI Stock Poised For Massive Gains: 10000% Upside Potential
Through portfolio optimization, productivity initiatives, and disciplined brand investments, the company is improving profitability while leveraging the scale of its well-established brands. Its 5.19% dividend yield, supported by a $5.12 annual dividend and 54 consecutive years of dividend increases, highlights a long-standing commitment to shareholder returns, while an 18% dividend growth rate over the past five years reinforces the strength of its cash-generating business despite an elevated 83.07% payout ratio.
The company’s fourth-quarter 2025 results demonstrated the effectiveness of this strategy, with net sales declining slightly by 0.6% to $4.08 billion but net income increasing to $499 million, operating profit rising to $507 million, and adjusted EPS growing 24% to $1.86, reflecting meaningful productivity gains and an improved product mix. For the full year, Kimberly-Clark generated $16.4 billion in sales, delivered 1.7% organic growth, and increased adjusted EPS to $7.53.
Looking ahead, management expects organic sales growth at or above category growth, mid- to high-single-digit adjusted operating profit growth, double-digit constant-currency adjusted EPS growth, and approximately $2 billion in adjusted free cash flow, supported by innovation, productivity, and additional portfolio changes related to the Kenvue transaction.
While execution, the elevated payout ratio, and category maturity remain key risks, Kimberly-Clark’s strong brands, pricing power, operational improvements, and transformation strategy position it for continued earnings growth and dependable long-term shareholder returns.
Previously, we covered a bullish thesis on Colgate-Palmolive Company (CL) by Kontra in October 2024, which highlighted the company’s defensive qualities, premium brands, pricing power, and ability to compound value through consistent growth. CL’s stock price has depreciated by approximately 9.35% since our coverage. MaxDividends shares a similar view but emphasizes Kimberly-Clark’s transformation strategy, productivity gains, and dividend strength.
Kimberly-Clark Corporation is not on our list of the 40 Most Popular Stocks Among Hedge Funds. As per our database, 59 hedge fund portfolios held KMB at the end of the first quarter which was 56 in the previous quarter. While we acknowledge the risk and potential of KMB as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than KMB and that has 10,000% upside potential, check out our report about this cheapest AI stock.
Disclosure: None.
